Michel Goedert is a Programme Leader at the Medical Research Council Laboratory of Molecular Biology in Cambridge, United Kingdom. His work established that tau protein is the central component of the paired helical filaments of Alzheimer’s disease and that alpha-synuclein is the major component of the filamentous inclusions of Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy.
Lead PI (Core Leadership)
Michel Goedert, MD, PhD
MRC Laboratory of Molecular Biology
Michel Goedert is a Programme Leader at the Medical Research Council Laboratory of Molecular Biology in Cambridge, United Kingdom. His work established that tau protein is the central component of the paired helical filaments of Alzheimer’s disease and that alpha-synuclein is the major component of the filamentous inclusions of Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy.
